Home › Compare › EMHTF vs ORCC

EMHTF vs ORCC: Dividend Comparison 2026

EMHTF yields 4938.27% · ORCC yields 9.79%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EMHTF wins by $55146348937607.22M in total portfolio value
10 years
EMHTF
EMHTF
● Live price
4938.27%
Share price
$0.04
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$55146348937607.24M
Annual income
$53,033,758,961,414,200,000.00
Full EMHTF calculator →
ORCC
ORCC
● Live price
9.79%
Share price
$13.48
Annual div
$1.32
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.4K
Annual income
$1.04
Full ORCC calculator →

Portfolio growth — EMHTF vs ORCC

📍 EMHTF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEMHTFORCC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EMHTF + ORCC cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
EMHTF pays
ORCC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EMHTF
Annual income on $10K today (after 15% tax)
$419,753.09/yr
After 10yr DRIP, annual income (after tax)
$45,078,695,117,202,070,000.00/yr
ORCC
Annual income on $10K today (after 15% tax)
$832.34/yr
After 10yr DRIP, annual income (after tax)
$0.88/yr
At 15% tax rate, EMHTF beats the other by $45,078,695,117,202,070,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EMHTF + ORCC for your $10,000?

EMHTF: 50%ORCC: 50%
100% ORCC50/50100% EMHTF
Portfolio after 10yr
$27573174468803.63M
Annual income
$26,516,879,480,707,100,000.00/yr
Blended yield
96.17%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ORCC right now

EMHTF
Analyst Ratings
1
Hold
Consensus: Hold
ORCC
Analyst Ratings
9
Buy
4
Hold
1
Sell
Consensus: Buy
Price Target
$16.00
+18.7% upside vs current
Range: $16.00 — $16.00
Altman Z
0.5
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EMHTF buys
0
ORCC buys
0
No recent congressional trades found for EMHTF or ORCC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEMHTFORCC
Forward yield4938.27% ✓9.79%
Annual dividend / share$2.00 ✓$1.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0% ✓-50%
Portfolio after 10y$55146348937607.24M ✓$21.4K
Annual income after 10y$53,033,758,961,414,200,000.00 ✓$1.04
Total dividends collected$55003355952995.54M ✓$1.0K
Payment frequencyquarterlyquarterly
SectorStockBDC
Analyst consensusHoldBuy

Year-by-year: EMHTF vs ORCC ($10,000, DRIP)

YearEMHTF PortfolioEMHTF Income/yrORCC PortfolioORCC Income/yrGap
1← crossover$504,527$493,827.16$11,190$489.61+$493.3K → EMHTF
2$23,824,817$23,284,973.37$12,229$256.01+$23.81M → EMHTF
3$1,053,123,085$1,027,630,530.32$13,216$130.74+$1053.11M → EMHTF
4$43,579,292,978$42,452,451,277.21$14,207$66.02+$43579.28M → EMHTF
5$1,688,429,051,261$1,641,799,207,774.13$15,234$33.17+$1688429.04M → EMHTF
6$61,254,845,187,941$59,448,226,103,092.12$16,317$16.62+$61254845.17M → EMHTF
7$2,081,181,684,947,090$2,015,639,000,595,993.00$17,468$8.32+$2081181684.93M → EMHTF
8$66,229,598,087,621,200$64,002,733,684,727,816.00$18,695$4.16+$66229598087.60M → EMHTF
9$1,974,383,155,320,608,300$1,903,517,485,366,853,600.00$20,006$2.08+$1974383155320.59M → EMHTF
10$55,146,348,937,607,240,000$53,033,758,961,414,200,000.00$21,407$1.04+$55146348937607.22M → EMHTF

EMHTF vs ORCC: Complete Analysis 2026

EMHTF — Stock

Emerald Health Therapeutics, Inc., together with its subsidiaries, engages in the production, distribution, and sale of recreational and medical cannabis in Canada. It offers dried cannabis strains, pre-rolled cannabis, oral sprays, nano emulsion shots, and cannabis oil products under the SYNC Wellness, fuse, Emerald, and Souvenir brands. The company was formerly known as T-Bird Pharma Inc. and changed its name to Emerald Health Therapeutics, Inc. in June 2015. Emerald Health Therapeutics, Inc. is headquartered in Vancouver, Canada. As of November 10, 2022, Emerald Health Therapeutics, Inc. operates as a subsidiary of Skye Bioscience, Inc.

Full EMHTF Calculator →

ORCC — BDC

Owl Rock Capital Corporation is a business development company. The fund makes investments in senior secured or unsecured loans, subordinated loans or mezzanine loans and also considers equity-related securities including warrants and preferred stocks also pursues preferred equity investments and common equity investments. Within private equity, it seeks to invest in growth, acquisitions, market or product expansion, refinancings and recapitalizations. It seeks to invest in middle market companies based in the United States, with EBITDA between $10 million and $250 million annually and/or annual revenue of $50 million and $2.5 billion at the time of investment.

Full ORCC Calculator →
📬

Get this EMHTF vs ORCC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EMHTF vs SCHDEMHTF vs JEPIEMHTF vs OEMHTF vs KOEMHTF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.